The Republic of Korea has issued a proposed update to its regulatory framework for in vitro diagnostic medical devices, inviting public comments before finalization.
Key points
- Proposed amendments to Korea’s in vitro diagnostic medical device regulation
- Affects permission, notification, and review procedures
- Comment period ends on January 1, 2027
- Official notice available via WTO TBT Inquiry Point
- Importers must verify final requirements post-adoption
- Scope defined in the official regulatory document
What Changed and Its Scope
The Republic of Korea has proposed partial amendments to its Regulation on the Permission, Notification, Review, and other procedures for in vitro diagnostic medical devices. The notice concerns changes to the regulatory process for these devices, including potential updates to approval pathways, notification requirements, and review mechanisms.
The scope of the amendments is limited to in vitro diagnostic medical devices as defined under the current regulatory framework. Specific details on the nature and extent of the changes are set out in the official notice and should be reviewed in full to understand the implications for product compliance and market access.
Who Is Affected and What to Check
Importers, distributors, manufacturers, and regulatory representatives of in vitro diagnostic medical devices targeting the Korean market are affected by this proposed amendment. The changes may impact how devices are registered, notified, or reviewed for market entry.
Importers should carefully review the full text of the official notice via the WTO TBT Inquiry Point to understand the proposed procedural changes. Compliance with the final version will be required once the regulation is adopted, and stakeholders are encouraged to submit comments before the deadline.
FAQ
What types of medical devices are covered by this proposed amendment?
The proposed amendment applies to in vitro diagnostic medical devices as defined under Korea’s current regulatory framework. The exact scope, including product categories and intended uses, is specified in the official notice. Importers should consult the full text to determine if their products fall within the revised regulatory scope.
When will the new rules take effect?
The effective date is not specified in the source. The proposed amendments are currently open for public comment until January 1, 2027. Once finalized and published, the updated regulation will govern future submissions and approvals. Importers should monitor the official notice for the final effective date after adoption.
Official source: Korea, Republic of — Proposed partial amendments to the Regulation on the Permission, Notification, Review, Etc. of In Vitro Diagnostic Medical Devices (2026-11-02)
This is an informational summary based solely on the official source. It does not constitute legal advice. Importers must consult the full notice and a qualified compliance adviser to ensure adherence to the final regulation.
Leave a Reply